Pivotal bioVenture Partners China - aVenture Asset Manager Research
Location
Shanghai, CN
Founded
2017
Pivotal bioVenture Partners China specializes in venture building within the life sciences industry. As a member of Nan Fung Life Sciences, the firm focuses on identifying innovative products and technologies in the biotech sector. Their investment strategy targets early-stage opportunities, with a track record of participating in seed and Series B rounds.
The firm's portfolio includes notable companies such as OncXerna Therapeutics, which has raised $96.5 million to date. Pivotal bioVenture Partners China aims to bring promising innovations to serve the growing unmet medical needs in China and globally. Their approach combines capital investment with strategic support to help portfolio companies accelerate growth and development in the competitive life sciences market.
Pivotal bioVenture Partners China - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
